ResMed (RMD) Stock Forecast & Price Target
Score
ResMed Inc. price target
| RMD | |
|---|---|
| Low | $213.00 |
| Average | $246.89 |
| High | $300.00 |
| Upside vs current price | +3.1% |
The average target of $246.89 is +3.1% versus the current RMD price of $239.53.
ResMed Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 2 |
| Buy | 8 |
| Hold | 10 |
| Sell | 1 |
| Strong sell | 0 |
| Consensus | Buy |
21 analysts cover RMD.
ResMed Inc. EPS and revenue estimates
Published annual figures for RMD on this page are 2027 EPS $12.14, 2028 EPS $13.25. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2027 | $12.14 | $5.83B |
| 2028 | $13.25 | $6.19B |
Is ResMed Inc. a buy or sell?
Of the 21 analysts covering ResMed Inc., 10 rate it a buy (2 strong buy and 8 buy), 10 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).
The RMD consensus label is Buy, beside 10 buy-side ratings and 1 sell-side ratings.
The average target of $246.89 implies +3.1% versus the current price of $239.53.
The RMD rating block is 21 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the ResMed Inc. forecast
the ResMed Inc. is priced by the street between $213.00 and $300.00, average $246.89.
The gap from the $239.53 price to the RMD average is +3.1%.
the ResMed Inc. does not have a single rating camp: 10 of 21 analysts are on the buy side, 10 are at hold, and 1 is on the sell side, and the published consensus is Buy.
The latest RMD actions do not point one way: 1 up and 1 down.
Month by month, the RMD average target is higher ($270.00) than the quarterly average ($253.80).
the ResMed Inc. is followed by 21 analysts, so the range matters more than any one target.
ResMed Inc. forecast questions
What is the RMD price target?
The published range for RMD is $213.00 to $300.00, with an average of $246.89. That average is +3.1% versus the current price of $239.53.
Is ResMed Inc. a buy or sell?
Of the 21 analysts covering ResMed Inc., 10 rate it a buy, 10 rate it a hold, and 1 rates it a sell. The consensus is Buy, leaving RMD at 10 buy ratings, 10 holds, and 1 sells.
What is the EPS estimate for ResMed Inc.?
Analyst EPS estimates for ResMed Inc.: 2027 $12.14, 2028 $13.25.
What is the revenue estimate for ResMed Inc.?
Analyst revenue estimates for ResMed Inc.: 2027 $5.83B, 2028 $6.19B.
How many analysts cover RMD?
21 analysts cover RMD. Their consensus on RMD is Buy, across those 21.